Published on 5 December 2022
Description:
Sustainability and corporate social responsibility; best practice in clinical research; challenges in data protection.
Categories:
Pharmaceutical Market EuropePreview:
28 articles from this collection:
PME April 2022
2 - PMLIVE
3 - Comment
4 - PMLIVE
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Creative destruction
12 - Pharma Market Europe Darwin’s medicine
13 - QIC Dermatology
14 - MIKE DIXON - Retrospective prospective
15 - PHARMA STRATEGIST’S BLOG - How and when should we innovate our strategies to deliver competitive advantage?
16-17 - RARE DRUG PRICING - Assessing the impact of rarity on French HTA and pricing decisions
18-19 - DIVERSITY IN CLINICAL TRIALS - Addressing the diversity issue in clinical trials
20-21 - CARDIOVASCULAR DISEASE - Global leaders in digital channels
22-23 - TL HANOVER - Unlocking the potential of data sharing
24 - TL COUCH- Implicit bias in treatment impacts clinical trials too
25 - DECEMBER Highlights
26-31 - PMEA 2022
32-33 - CORPORATE SOCIAL RESPONSIBILITY - Pharma’s vital role in sustainability and corporate social responsibility
34 - TL MHP Group - Why pharma needs to ‘walk the talk’ on improving the greener patient journey
35 - DATA PROTECTION - The challenges of the proposed Data Protection and Digital Information Bill
36-37 - BEST PRACTICE - Design considerations and best practices in clinical research
38-40 - Appointments
41 - HEALTHCARE COMMS
42 - WORLD AMR WEEK 2022 - World Antimicrobial Awareness Week 2022
43 - PHARMAROLE
43 - Pharma Market Europe (PME) Recruitment
44 - PM SOCIETY AWARDS
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services